What Raises Troponins in the Paediatric Population?
Troponin I is a cardiac enzyme that is released during myocardial injury. However, cardiac enzymes are non-specific and can occur in many cardiac and non-cardiac pathologies. We aim to (1) describe the range of acute conditions that were associated with raised troponins in the paediatric population in our institution and (2) quantify the extent of troponin elevation and correlate it with the underlying aetiology. We performed a retrospective observational study in a tertiary institution which included patients from 1 January 2009 to 31 December 2013. We identified patients with troponin I levels of more than 0.1 ng/ml who have not had cardiac surgery before. We recorded their final diagnoses, and then compared the peak troponin levels and the eventual final diagnoses. We identified 100 patients. The top few common diagnoses resulting in a raised troponin were sepsis (29%), cardiac pathologies (29%) such as tachyarrhythmias and cardiomyopathies and myocarditis (21%). Other pathologies included trauma and other causes of multiorgan dysfunction. The median peak troponin I was higher in cardiac as compared to non-cardiac pathologies: 2.15 (0.52–15.0) and 0.44 (0.21–1.68), respectively. There was no statistically significant difference in the peak troponin I values in the presence of hypotension or renal impairment. We described the range of conditions that may result in raised troponin I levels. The extent of raised troponin I levels may potentially be useful in differentiating between cardiac and non-cardiac pathologies. However, further studies on a larger scale are required to establish whether extent of troponin I elevation has a diagnostic role for cardiac pathologies.
KeywordsPaediatric Troponin Aetiology Cardiac
Compliance with Ethical Standards
Conflict of interest
The authors declare that there is no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study formal consent is not required.
- 4.Kanaan UB, Chiang VW (2004) Cardiac troponins in pediatrics. Pediatr Emerg Care 20(5):323–329. https://doi.org/10.1097/01.pec.0000125664.35690.51 CrossRefPubMedGoogle Scholar
- 12.El-Menyar A, Mahmood I, Dabdoob W, Abdulrahman Y, Siddiqui T, Atique S, Al-Thani H (2016) Troponin T in patients with traumatic chest injuries with and without cardiac involvement: insights from an observational study. N Am J Med Sci 8(1):17. https://doi.org/10.4103/1947-2714.175188 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Gurkan F, Alkaya A, Ece A et al (2004) Cardiac troponin-I as a marker of myocardial dysfunction in children with septic shock. Swiss Med Weekly 134:593–596Google Scholar
- 14.Fenton KE, Sable CA, Bell MJ, Patel KM, Berger JT (2004) Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock. Pediatr Crit Care Med 5(6):533–538. https://doi.org/10.1097/01.pcc.0000144711.97646.0c CrossRefPubMedGoogle Scholar
- 16.Velmahos GC, Karaiskakis M, Salim A, Toutouzas KG, Murray J, Asensio J, Demetriades D (2003) Normal electrocardiography and serum troponin i levels preclude the presence of clinically significant blunt cardiac injury. J Trauma Inj Infect Crit Care 54(1):45–51. https://doi.org/10.1097/00005373-200301000-00006 CrossRefGoogle Scholar